Analyst firms · Raymond James · MDT
Raymond James MDT price target and rating history
Medtronic plc. (MDT) · Health Care
Raymond James rates Medtronic plc. (MDT) Mkt Perform with a $116 price target, as of its latest action on Aug 24, 2022. It has published 3 rating actions on MDT since August 2021, including 0 upgrades and 1 downgrade. Across 8 firms with a MDT price target in the last 12 months, the median target is $107.
- Current rating
- Mkt Perform
- Price target
- $116
- Median target, all firms
- $107
- Actions on MDT
- 3
Raymond James price target on MDT
Every Raymond James rating on MDT
- Aug 24, 2022
- Feb 18, 2022
- Aug 25, 2021
How other firms rate MDT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $120 | Nov 17, 2026 |
| Barclays | Equal Weight | $95 | Oct 7, 2026 |
| Needham | Buy | $114 | Aug 27, 2026 |
| UBS | Buy | $100 | Jul 28, 2026 |
| BTIG | Buy | $90 | Jun 4, 2026 |
| Goldman Sachs | Neutral | $84 | May 21, 2026 |
| Citigroup | Buy | $117 | Feb 3, 2026 |
| Wells Fargo | Overweight | $114 | Jan 30, 2026 |
| William Blair | Outperform | Jan 6, 2026 |
Questions about Raymond James and MDT
- What is Raymond James's price target for MDT?
- Raymond James's latest stated price target for Medtronic plc. (MDT) is $116, from its action on Feb 18, 2022.
- What is Raymond James's rating on MDT?
- Raymond James rates MDT Mkt Perform, a neutral rating, as of Aug 24, 2022.
- When did Raymond James last change its view on MDT?
- On Aug 24, 2022, Raymond James downgrades to Mkt Perform from Outperform.
- How does Raymond James's MDT target compare with other analysts?
- Across 8 firms with a MDT price target in the last 12 months, the median target is $107.
More MDT rating histories
- Piper Sandler3
- Barclays3
- Needham7
- UBS4
- BTIG3
- Goldman Sachs4
- Citigroup6
- Wells Fargo6
- RBC Capital Markets3
- Oppenheimer4
- Morgan Stanley4
- Truist Securities3
- Credit Suisse3
All Raymond James ratingsMDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.